These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 29787950

  • 1. Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells.
    Xu W, Ge P, Niu B, Zhang X, Liu J, Xie J.
    J Colloid Interface Sci; 2018 Oct 01; 527():141-150. PubMed ID: 29787950
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, Cao X, Zhang H.
    Mater Sci Eng C Mater Biol Appl; 2018 Mar 01; 84():108-117. PubMed ID: 29519418
    [Abstract] [Full Text] [Related]

  • 6. Macroporous organosilicon nanocomposites co-deliver Bcl2-converting peptide and chemotherapeutic agent for synergistic treatment against multidrug resistant cancer.
    Xie J, Xu W, Wu Y, Niu B, Zhang X.
    Cancer Lett; 2020 Jan 28; 469():340-354. PubMed ID: 31629930
    [Abstract] [Full Text] [Related]

  • 7. Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy.
    Ma B, He L, You Y, Mo J, Chen T.
    Drug Deliv; 2018 Nov 28; 25(1):293-306. PubMed ID: 29334793
    [Abstract] [Full Text] [Related]

  • 8. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D, Gao Y, Wang L, Liu G, Chen Y, Wang T, Tao W, Mei L, Huang L, Zeng X.
    J Colloid Interface Sci; 2016 Feb 01; 463():279-87. PubMed ID: 26550786
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In Situ Synthesis of Ultrathin ZIF-8 Film-Coated MSNs for Codelivering Bcl 2 siRNA and Doxorubicin to Enhance Chemotherapeutic Efficacy in Drug-Resistant Cancer Cells.
    Pan QS, Chen TT, Nie CP, Yi JT, Liu C, Hu YL, Chu X.
    ACS Appl Mater Interfaces; 2018 Oct 03; 10(39):33070-33077. PubMed ID: 30203954
    [Abstract] [Full Text] [Related]

  • 11. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X, Teh C, Zhang Q, Borah P, Choong C, Korzh V, Zhao Y.
    Antioxid Redox Signal; 2014 Aug 10; 21(5):707-22. PubMed ID: 23931896
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J, Sun Y, Tian B, Li K, Wang L, Liang Y, Han J.
    Colloids Surf B Biointerfaces; 2016 Aug 01; 144():293-302. PubMed ID: 27107383
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy.
    Liang C, Wang H, Zhang M, Cheng W, Li Z, Nie J, Liu G, Lian D, Xie Z, Huang L, Zeng X.
    J Colloid Interface Sci; 2018 Sep 01; 525():1-10. PubMed ID: 29679795
    [Abstract] [Full Text] [Related]

  • 17. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X, Wang Y, Peng B.
    Chem Asian J; 2014 Jan 01; 9(1):319-27. PubMed ID: 24115568
    [Abstract] [Full Text] [Related]

  • 18. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.
    Wu X, Zheng Y, Yang D, Chen T, Feng B, Weng J, Wang J, Zhang K, Zhang X.
    J Mater Chem B; 2019 Jan 21; 7(3):477-487. PubMed ID: 32254735
    [Abstract] [Full Text] [Related]

  • 19. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
    Zhang X, Li F, Guo S, Chen X, Wang X, Li J, Gan Y.
    Biomaterials; 2014 Apr 21; 35(11):3650-65. PubMed ID: 24462359
    [Abstract] [Full Text] [Related]

  • 20. Superior doxorubicin cellular delivery effect established by optically active mesoporous silica nanoparticles.
    Wang L, Yu D, Li D, Li J.
    Drug Deliv Transl Res; 2024 Nov 21; 14(11):3163-3172. PubMed ID: 38381319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.